HZ and stroke risk: Implications for zoster vaccination
10 Mar 2026
byDr. Kay-Cheong Teo, Specialist in Neurology, University of Hong Kong; Dr. Anthony Tam, Specialist in Infectious Disease, University of Hong Kong
In an interview with MIMS Doctor, Dr Kay-Cheong
Teo, Specialist in Neurology, and Dr Anthony Tam, Specialist in Infectious
Disease, both from the University of Hong Kong, discussed the intricate herpes
zoster (HZ)–stroke relationship. They also highlighted how recombinant zoster
vaccine (RZV), with its high efficacy and favourable safety profile, can play a
significant role in preventing HZ, mitigating varicella zoster virus
(VZV)–related sequelae such as debilitating post-herpetic neuralgia (PHN), and
potentially reducing stroke risk, as demonstrated by recent cohort studies.